Cutaneous Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Cutaneous Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus [Phase 2, Phase 3]
Biogen is conducting a two-part Phase 2/3 trial evaluating litifilimab (BIIB059) for adults with active cutaneous lupus erythematosus; the s…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) [Phase 2]
A Phase 2 clinical trial evaluating safety, tolerability, and efficacy of IMVT-1402 in adults with subacute and chronic cutaneous lupus eryt…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus [Phase 3]
This clinical trial update describes a long-term extension study evaluating the safety of Litifilimab (BIIB059) injections and its potential…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus [Phase 2]
A Phase 2a multicenter randomized, double-blind, placebo-controlled study assessing the efficacy and safety of VENT-03 in adults with active…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) [Phase 3]
A Phase 3 clinical trial evaluating Enpatoran for cutaneous lupus manifestations with or without systemic lupus erythematosus is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease [Phase 3]
A Phase 3 clinical trial evaluating enpatoran for cutaneous lupus manifestations in patients with or without systemic lupus erythematosus is…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Ongoing clinical trial assessing the prevalence and severity of Cutaneous Lupus Erythematosus and recruiting participants.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus [Phase 3]
A Phase 3 trial evaluating anifrolumab for chronic and/or subacute cutaneous lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease [Phase 1]
Phase 1 study of S-4321 in autoimmune and immune-mediated diseases; the trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study [Phase 2]
A Phase 2 double-blind clinical trial evaluating ICP-488 for efficacy and safety in subjects with Cutaneous lupus erythematosus; the study i…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. [Phase 1]
Phase 1 trial evaluating ACT100 in healthy participants to characterize safety, tolerability, and PK/PD. The study is sponsored by Xiamen Am…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE [Phase 1]
Phase 1 trial update evaluating safety, tolerability, pharmacokinetics, immunogenicity and preliminary efficacy of HC022 injection in system…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Research Accelerated by You Lupus Registry
This clinical trial registry entry describes the Lupus Registry study sponsored by the Lupus Foundation of America, which is currently recru…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Duke Lupus Registry
This ClinicalTrials.gov entry reports that the Duke Lupus Registry study is currently recruiting participants for research on systemic lupus…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Cutaneous Lupus Registry
A registry study focused on cutaneous lupus erythematosus, sponsored by UT Southwestern Medical Center, is currently recruiting participants…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants [EARLY_Phase 1]
An early Phase 1 trial from Noxopharm evaluates the safety, tolerability, and pharmacokinetics of the SOF-SKN combination in healthy partici…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial comparing lenalidomide to methotrexate for difficult-to-treat cutaneous lupus erythematosus, with recruitment not y…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Tapinarof for Cutaneous Lupus Erythematosus [EARLY_Phase 1]
Northwestern University reports an early Phase 1 trial evaluating tapinarof for cutaneous lupus erythematosus; the study is currently enroll…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis [Phase 1]
Amgen's Phase 1 study evaluating VIB7734 in multiple autoimmune diseases including systemic lupus erythematosus, cutaneous lupus erythematos…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
This clinical trial update describes a study to identify cutaneous and blood biomarkers that predict response to systemic treatments across …
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
A clinical trial evaluating adherence to treatment and satisfaction with care in patients with cutaneous lupus erythematosus; currently recr…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Deep Phenotyping of Cutaneous Lupus Erythematosus [NA]
This clinical trial is recruiting to deeply phenotype Cutaneous Lupus Erythematosus to better understand its clinical and molecular features…
-
CLINICAL_TRIALS research · 2023-08-25Clinical Trial Update: Low-dose UVA1 Radiation in Cutaneous Lupus Patients [NA]
Clinical trial completed assessing low-dose UVA1 radiation in patients with cutaneous lupus erythematosus; results posted in 2023.
-
CLINICAL_TRIALS research · 2021-12-16Clinical Trial Update: Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases [Phase 4]
A Phase 4 trial evaluating the relevance of monitoring blood and salivary levels of drugs used in rheumatic autoimmune diseases, including S…